Search results for

John talks with NPR's Ketzel Levine about plants that do well in offices. While many plants will shrivel under fluorescent light, plants that are suited to irregular care and indirect light can thrive. Listeners can follow along on Ketzel's web site, Talking Plants. (6:30)

Robert reads from listeners' letters. Topics include moving to small towns and last week's blue moon. Letters should be addressed to LETTERS - All Things Considered. 6-3-5 Massachusetts Avenue, Northwest, Washington D-C 20001. Or by E-Mail ATC@NPR.ORG. (5:00) (***STER

Beth Fertig of member station WNYC reports on an investigation by New York City and by the state that shows how the case of abused-to-death 6 year old Elisa was bungled...and how other cases have also slipped through the social welfare cracks.

Nick Spitzer reviews the latest CD from Johnny Cash. It's called "Unchained" and features Cash at his most rocking ever. (STATIONS: "Unchained" is on the American Recordings label, catalog number 9-43097-2) (6:00) ((ST

NPR's Peter Kenyon reports on a congressional race in Alabama pitting a longtime Democratic state senator against a Republican businessman who's never held elected office. (6:00) [outcue: "... affecting the balance of power in the House next year. I'm Peter Kenyon reporting."

After a year when NASDAQ tech stocks finished off nearly 40 percent and the Dow Jones Industrial Average dropped 6.2 percent, economic advisor Owen Ullman looks ahead.

Verizon Communications has sealed a $6.7 billion deal to buy long-distance provider MCI. NPR's Madeleine Brand talks to Matthew Algeo of Marketplace.

Pete Hegseth reportedly shared details about Yemen strikes in a second group chat with his wife and brother. Rep. Jim Himes, D-Conn., says it's 'not shocking' based on behavior out of the Pentagon.

When CIA officers walk out of the U.S. Embassy in Moscow, they're shadowed by Russian security. A new book examines how they have operated with this round-the-clock surveillance.

In 2011, just 41 health care providers prescribed more than $5 million each in medicines under Medicare Part D. In 2015, that number was 514. The rise of expensive hepatitis C drugs is a factor.